Calumet (NASDAQ:CLMT – Get Free Report) had its price objective cut by equities research analysts at TD Cowen from $40.00 to $37.00 in a research note issued on Wednesday, Benzinga reports. The firm presently has a “hold” rating on the oil and gas company’s stock. TD Cowen‘s target price suggests a potential upside of 19.05% from the stock’s previous close.
CLMT has been the topic of several other research reports. Wall Street Zen raised Calumet from a “hold” rating to a “buy” rating in a report on Saturday, November 14th. UBS Group lifted their price target on Calumet from $26.00 to $47.00 and gave the stock a “neutral” rating in a report on Tuesday, August 25th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Calumet in a research report on Wednesday, November 4th. Citigroup reaffirmed a “buy” rating on shares of Calumet in a research report on Monday, August 10th. Finally, The Goldman Sachs Group reiterated a “neutral” rating and issued a $57.00 price objective on shares of Calumet in a report on Wednesday, October 21st. Two investment analysts have rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Calumet currently has an average rating of “Hold” and an average price target of $54.00.
Get Our Latest Stock Analysis on Calumet
Calumet Trading Up 2.5%
Calumet (NASDAQ:CLMT – Get Free Report) last announced its quarterly earnings data on Friday, November 6th. The oil and gas company reported $2.91 earnings per share for the quarter, beating analysts’ consensus estimates of $1.63 by $1.28. The business had revenue of $1.68 billion for the quarter, compared to analyst estimates of $1.34 billion. Calumet had a negative net margin of 3.73% and a negative return on equity of 32.93%. The company’s revenue was up 56.1% on a year-over-year basis. During the same period last year, the business earned $3.61 EPS. As a group, equities research analysts expect that Calumet will post 3.09 EPS for the current year.
Institutional Investors Weigh In On Calumet
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Zacks Investment Management purchased a new position in shares of Calumet during the third quarter worth approximately $218,000. BlueCrest Capital Management Ltd raised its position in Calumet by 12.5% in the 3rd quarter. BlueCrest Capital Management Ltd now owns 90,000 shares of the oil and gas company’s stock valued at $4,714,000 after purchasing an additional 10,000 shares during the last quarter. Toronto Dominion Bank purchased a new stake in Calumet in the 3rd quarter valued at $291,000. FORA Capital LLC acquired a new stake in Calumet during the 3rd quarter worth $923,000. Finally, Caxton Associates LLP acquired a new stake in Calumet during the 3rd quarter worth $3,660,000. Hedge funds and other institutional investors own 34.41% of the company’s stock.
About Calumet
Calumet, Inc. is a U.S.-based producer of specialty hydrocarbon products, renewable fuels and conventional fuels. Its products serve customers in industries such as manufacturing, transportation, energy and consumer goods. The company’s specialty products include lubricating oils, solvents, waxes, petrolatums and asphalt. It also produces gasoline, diesel and other fuels, and through its Montana Renewables business makes lower-carbon fuels, including sustainable aviation fuel and renewable diesel.
Further Reading
- Five stocks we like better than Calumet
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
Receive News & Ratings for Calumet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calumet and related companies with MarketBeat.com's FREE daily email newsletter.
